NCT02780258

Brief Summary

To evaluate the safety and efficacy of Restylane Silk for photoaged thinned hands

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 23, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2016

Completed
Last Updated

April 17, 2018

Status Verified

April 1, 2018

Enrollment Period

1 year

First QC Date

May 19, 2016

Last Update Submit

April 16, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in photoaged thinning of the treatment area as measured by the 5 point hand grading scale

    Baseline, 1month, 3months, 6 months

Study Arms (2)

Restylane Silk Treated Hand

EXPERIMENTAL

The dorsal aspect of one hand will be injected with Restylane Silk.

Device: Restylane Silk

Control Hand

NO INTERVENTION

The dorsal aspect of the hand that is not treated will be used for baseline comparison.

Interventions

Restylane Silk Treated Hand

Eligibility Criteria

Age40 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female volunteer
  • Aged from 40-70 years on the day of screening
  • No known medical conditions that may interfere with study participation
  • Moderate to very severe Photoaged thinning of the hands based on the 5-point hand grading scale
  • Willingness to not use any products on their hands for the duration of the study
  • Read, understand, and sign informed consent forms
  • Willingness to sign photography release form
  • Willing and able to comply with all follow-up requirements
  • Willingness to undergo Restylane Silk injections to one hand

You may not qualify if:

  • Any significant skin disease at treatment area
  • Any medical condition which could interfere with the treatment
  • Inability or unwillingness to follow the treatment schedule
  • Inability or unwillingness to sign the informed consent
  • History of poor wound healing
  • History of keloid formation
  • History of HIV, hepatitis, immuno-compromised
  • Pregnant or lactating
  • Previous use of deep chemical peels on the treatment area
  • Previous injections of Restylane Silk to the hands
  • Known hypersensitivity to Restylane Silk or any of its ingredients
  • Previous laser or light based treatments to the treatment area 6 months prior to the screening visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
David J. Goldberg, MD, JD

Study Record Dates

First Submitted

May 19, 2016

First Posted

May 23, 2016

Study Start

October 20, 2015

Primary Completion

October 28, 2016

Study Completion

October 28, 2016

Last Updated

April 17, 2018

Record last verified: 2018-04